Entry Point Capital, LLC Staar Surgical CO Call Options Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STAA
# of Institutions
255Shares Held
47.8MCall Options Held
427KPut Options Held
206K-
Broadwood Capital Inc New York, NY10.8MShares$287 Million31.02% of portfolio
-
Black Rock Inc. New York, NY7.49MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$147 Million0.0% of portfolio
-
State Street Corp Boston, MA1.94MShares$51.7 Million0.0% of portfolio
-
Baillie Gifford & CO1.46MShares$38.9 Million0.04% of portfolio
About STAAR SURGICAL CO
- Ticker STAA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 48,038,300
- Market Cap $1.28B
- Description
- STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...